Leef Brands (LEEEF) Cash from Operations (2025 - 2026)

Leef Brands (LEEEF) reported Cash from Operations of 395001.0 for Q1 2026, up 121.51% on a YoY basis from 178320.58 in Q1 2025, and up 121.51% sequentially from 1836212.0 in Q1 2025.

Leef Brands (LEEEF) Cash from Operations (2025 - 2026) Analysis & Trends

Leef Brands (LEEEF) has 2 years of Cash from Operations data on file, last reported at 395001.0 in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -40.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 401.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.58 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 463.30 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 388.30 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 145.80 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 13.00 Mn
10 Leef Brands 51.94 Mn 46.18 Mn 4.62 Mn 395,001.00

Historic Data

Download Data
DateValue
Mar 31, 2026 395,001.00
Mar 31, 2026 395,001.00
Mar 31, 2025 -1.84 Mn
Mar 31, 2025 -1.84 Mn